ENvue Medical will reduce its outstanding common stock from 11,084,616 shares to approximately 923,718 through a Reverse Stock Split effective September 1, 2026. The company says proportional ownership, voting power, dividends and distributions will remain unchanged, apart from minimal effects tied to fractional-share treatment.

Key Highlights

  • ENvue Medical’s authorized common stock will remain 40,000,000 shares after the reverse split.
  • The common stock will continue trading under FEED on the Nasdaq Capital Market.
  • Fractional shares will be rounded up, while options, convertible securities, restricted stock, units and warrants will be adjusted.

ENvue Medical, Inc. (NASDAQ: FEED) will consolidate its outstanding common stock, reducing the total from 11,084,616 shares to approximately 923,718 shares when the reverse stock split takes effect on September 1, 2026. The company says proportional ownership and voting power will remain unchanged, except for minimal effects from fractional-share treatment.

923,718 Shares After September 1 Split

The reverse stock split follows approval by ENvue Medical’s board under authority granted at a special stockholders meeting held on August 14, 2026. The authorized common stock will remain 40,000,000 shares, and the Par Value of the common stock and preferred stock will not change. Outstanding options, convertible securities including preferred stock, vested and unvested restricted stock, restricted stock units and warrants will receive corresponding adjustments. Following the transaction, common stockholders will retain the same proportional rights to vote and receive dividends and distributions. Chief Executive Officer Doron Besser, M.D. Signed the company’s report dated August 31, 2026.

Peers Moving on This News